Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).

Inclusion Criteria: * Women 18 years or older, inclusive * Diagnosis of OAB or mixed incontinence with the predominance of OAB symptoms * Dissatisfaction with any current or previous pharmacotherapy treatment of OAB for any reason within the past 12 months * Treatment Satisfaction VAS \<50 * Ability to understand and sign ICF * Subject agreed to attend all follow up evaluations and was willing to completely and accurately fill out voiding diaries and questionnaires, and was willing to complete required exams and tests * Subject agreed not to participate in another research study from the time of screening until the final study visit * Subject agreed not to use a pharmacotherapy treatment for OAB from the time of screening until the final study visit Exclusion Criteria: * Prior treatment with botulotoxin for OAB * Previous pharmacotherapy for OAB if \>12 months ago * Urinary retention with post void residual \> 150ml * Neurological disease affecting urinary bladder function, including but not limited to Parkinson's disease, multiple sclerosis, stroke, spinal cord injury and nerves of lower limbs * History or presence of stress incontinence, or mixed incontinence where stress incontinence was predominant